It has been suggested that, owing to the impact of IL-6 on hepatocytes, IL-6 may function in activating PLP phosphatase activity, thus decreasing circulating PLP concentrations (McCarty, 2000), though this remains to be assessed in patients with depression. This evidence concerns the gene PDXP and depressive symptom measurement.